ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients

NCT01464827 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

580

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C
Hepatitis C (HCV)
Hepatitis C Genotype 1

Interventions

DRUG: ABT-450
DRUG: ABT-333
DRUG: ABT-267
DRUG: Ribavirin
DRUG: Ritonavir

Sponsor

AbbVie (prior sponsor, Abbott)